vs
Forestar Group Inc.（FOR）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Forestar Group Inc.的1.8倍（$493.8M vs $273.0M），Pediatrix Medical Group, Inc.净利率更高（6.8% vs 5.6%，领先1.2%），Forestar Group Inc.同比增速更快（9.0% vs -1.7%），过去两年Pediatrix Medical Group, Inc.的营收复合增速更高（-0.1% vs -9.6%）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
FOR vs MD — 直观对比
营收规模更大
MD
是对方的1.8倍
$273.0M
营收增速更快
FOR
高出10.7%
-1.7%
净利率更高
MD
高出1.2%
5.6%
两年增速更快
MD
近两年复合增速
-9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $493.8M |
| 净利润 | $15.4M | $33.7M |
| 毛利率 | 20.1% | — |
| 营业利润率 | 7.6% | 9.9% |
| 净利率 | 5.6% | 6.8% |
| 营收同比 | 9.0% | -1.7% |
| 净利润同比 | -6.7% | 10.5% |
| 每股收益（稀释后） | $0.30 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORMD
| Q4 25 | $273.0M | $493.8M | ||
| Q3 25 | $670.5M | $492.9M | ||
| Q2 25 | $390.5M | $468.8M | ||
| Q1 25 | $351.0M | $458.4M | ||
| Q4 24 | $250.4M | $502.4M | ||
| Q3 24 | $551.3M | $511.2M | ||
| Q2 24 | $318.4M | $504.3M | ||
| Q1 24 | $333.8M | $495.1M |
净利润FORMD
| Q4 25 | $15.4M | $33.7M | ||
| Q3 25 | $86.9M | $71.7M | ||
| Q2 25 | $32.9M | $39.3M | ||
| Q1 25 | $31.6M | $20.7M | ||
| Q4 24 | $16.5M | $30.5M | ||
| Q3 24 | $81.5M | $19.4M | ||
| Q2 24 | $38.7M | $-153.0M | ||
| Q1 24 | $45.0M | $4.0M |
毛利率FORMD
| Q4 25 | 20.1% | — | ||
| Q3 25 | 22.3% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 22.6% | — | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | 22.5% | — | ||
| Q1 24 | 24.9% | — |
营业利润率FORMD
| Q4 25 | 7.6% | 9.9% | ||
| Q3 25 | 16.9% | 13.8% | ||
| Q2 25 | 11.2% | 12.8% | ||
| Q1 25 | 11.6% | 7.0% | ||
| Q4 24 | 8.7% | 7.8% | ||
| Q3 24 | 19.7% | 6.6% | ||
| Q2 24 | 16.2% | -31.3% | ||
| Q1 24 | 17.6% | 3.2% |
净利率FORMD
| Q4 25 | 5.6% | 6.8% | ||
| Q3 25 | 13.0% | 14.5% | ||
| Q2 25 | 8.4% | 8.4% | ||
| Q1 25 | 9.0% | 4.5% | ||
| Q4 24 | 6.6% | 6.1% | ||
| Q3 24 | 14.8% | 3.8% | ||
| Q2 24 | 12.2% | -30.3% | ||
| Q1 24 | 13.5% | 0.8% |
每股收益（稀释后）FORMD
| Q4 25 | $0.30 | $0.40 | ||
| Q3 25 | $1.70 | $0.84 | ||
| Q2 25 | $0.65 | $0.46 | ||
| Q1 25 | $0.62 | $0.24 | ||
| Q4 24 | $0.32 | $0.37 | ||
| Q3 24 | $1.59 | $0.23 | ||
| Q2 24 | $0.76 | $-1.84 | ||
| Q1 24 | $0.89 | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $375.2M |
| 总债务越低越好 | $793.2M | $570.5M |
| 股东权益账面价值 | $1.8B | $865.9M |
| 总资产 | $3.2B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资FORMD
| Q4 25 | $211.7M | $375.2M | ||
| Q3 25 | $379.2M | $340.1M | ||
| Q2 25 | $189.2M | $224.7M | ||
| Q1 25 | $174.3M | $99.0M | ||
| Q4 24 | $132.0M | $229.9M | ||
| Q3 24 | $481.2M | $103.8M | ||
| Q2 24 | $359.2M | $19.4M | ||
| Q1 24 | $416.2M | $8.0M |
总债务FORMD
| Q4 25 | $793.2M | $570.5M | ||
| Q3 25 | $802.7M | $577.2M | ||
| Q2 25 | $872.8M | $583.9M | ||
| Q1 25 | $872.5M | $590.5M | ||
| Q4 24 | $806.8M | $597.1M | ||
| Q3 24 | $706.4M | — | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | — |
股东权益FORMD
| Q4 25 | $1.8B | $865.9M | ||
| Q3 25 | $1.8B | $890.7M | ||
| Q2 25 | $1.7B | $833.8M | ||
| Q1 25 | $1.6B | $789.2M | ||
| Q4 24 | $1.6B | $764.9M | ||
| Q3 24 | $1.6B | $732.5M | ||
| Q2 24 | $1.5B | $706.5M | ||
| Q1 24 | $1.5B | $856.2M |
总资产FORMD
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $3.1B | $2.2B | ||
| Q2 25 | $3.1B | $2.1B | ||
| Q1 25 | $3.0B | $2.0B | ||
| Q4 24 | $3.0B | $2.2B | ||
| Q3 24 | $2.8B | $2.1B | ||
| Q2 24 | $2.7B | $2.0B | ||
| Q1 24 | $2.6B | $2.2B |
负债/权益比FORMD
| Q4 25 | 0.44× | 0.66× | ||
| Q3 25 | 0.45× | 0.65× | ||
| Q2 25 | 0.52× | 0.70× | ||
| Q1 25 | 0.53× | 0.75× | ||
| Q4 24 | 0.50× | 0.78× | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $114.1M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | — |
| 自由现金流率自由现金流/营收 | -57.5% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | -10.19× | 3.39× |
| 过去12个月自由现金流最近4个季度 | $93.0M | — |
8季度趋势，按日历期对齐
经营现金流FORMD
| Q4 25 | $-157.0M | $114.1M | ||
| Q3 25 | $256.3M | $137.3M | ||
| Q2 25 | $15.8M | $137.2M | ||
| Q1 25 | $-19.8M | $-117.5M | ||
| Q4 24 | $-450.0M | $133.0M | ||
| Q3 24 | $119.2M | $91.8M | ||
| Q2 24 | $-61.7M | $107.0M | ||
| Q1 24 | $-59.2M | $-125.2M |
自由现金流FORMD
| Q4 25 | $-157.1M | — | ||
| Q3 25 | $255.6M | — | ||
| Q2 25 | $15.0M | — | ||
| Q1 25 | $-20.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $118.4M | — | ||
| Q2 24 | $-62.3M | — | ||
| Q1 24 | $-59.8M | — |
自由现金流率FORMD
| Q4 25 | -57.5% | — | ||
| Q3 25 | 38.1% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | -5.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 21.5% | — | ||
| Q2 24 | -19.6% | — | ||
| Q1 24 | -17.9% | — |
资本支出强度FORMD
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率FORMD
| Q4 25 | -10.19× | 3.39× | ||
| Q3 25 | 2.95× | 1.91× | ||
| Q2 25 | 0.48× | 3.49× | ||
| Q1 25 | -0.63× | -5.66× | ||
| Q4 24 | -27.27× | 4.36× | ||
| Q3 24 | 1.46× | 4.72× | ||
| Q2 24 | -1.59× | — | ||
| Q1 24 | -1.32× | -31.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
